Danfeng Guo
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Immunology top 10%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
-
- Extracellular vesicles in disease 5
- Ubiquitin and proteasome pathways 3
- Heat shock proteins research 2
- Oncology 8
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Zhijian Cai (6 shared papers)Yunshan Yang (4 shared papers)Yingying Shen (3 shared papers)Shoujie Wang (2 shared papers)Jianli Wang (2 shared papers)Fei Yang (2 shared papers)Jianli Wang (3 shared papers)Yinghu Chen (1 shared paper)
- Journals
- Scientific Reports (2 papers)Journal of Enzyme Inhibition and Medicinal Chemistry (1 paper)Cellular and Molecular Immunology (1 paper)Immunology (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- ChinaJapanUnited Kingdom
In The Last Decade
Danfeng Guo
23 papers receiving 633 citations
Peers
Comparison fields: 5 of 85
- Cancer Research 166
- Immunology 227
- Rehabilitation 41
- Molecular Biology 367
- Oncology 103
Countries citing papers authored by Danfeng Guo
This map shows the geographic impact of Danfeng Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danfeng Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danfeng Guo more than expected).
Fields of papers citing papers by Danfeng Guo
This network shows the impact of papers produced by Danfeng Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danfeng Guo. The network helps show where Danfeng Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Danfeng Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 108 | |
| 2 | 2017 | 90 | |
| 3 | 2017 | 78 | |
| 4 | 2018 | 75 | |
| 5 | 2011 | 64 | |
| 6 | 2022 | 47 | |
| 7 | 2021 | 27 | |
| 8 | 2022 | 24 | |
| 9 | 2022 | 21 | |
| 10 | 2021 | 20 | |
| 11 | 2023 | 17 | |
| 12 | 2020 | 13 | |
| 13 | 2022 | 13 | |
| 14 | 2022 | 10 | |
| 15 | 2022 | 7 | |
| 16 | 2023 | 6 | |
| 17 | 2024 | 4 | |
| 18 | 2021 | 4 | |
| 19 | 2022 | 3 | |
| 20 | 2022 | 3 |
About Danfeng Guo
Danfeng Guo is a scholar working on Molecular Biology, Oncology, Immunology, Surgery and Epidemiology, having authored 23 papers that have together received 639 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (5 papers), Autophagy in Disease and Therapy (4 papers), Immunotherapy and Immune Responses (3 papers), Ubiquitin and proteasome pathways (3 papers), Cancer Research and Treatments (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Heat shock proteins research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Cancer Research (166 citations), Immunology (227 citations), Rehabilitation (41 citations), Molecular Biology (367 citations) and Oncology (103 citations). Danfeng Guo has collaborated with scholars based in China, Japan and United Kingdom. Frequent co-authors include Zhijian Cai, Yunshan Yang, Yingying Shen, Shoujie Wang, Jianli Wang, Fei Yang, Jianli Wang, Yinghu Chen, Haijun Zhong and Lei Yu. Their work appears in journals such as Scientific Reports, Journal of Enzyme Inhibition and Medicinal Chemistry, Cellular and Molecular Immunology, Immunology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.